1. Gullane PJ, Davidson J, O’Dwyer T, Forte V. Juvenile angiofibroma: a review of the literature and a case series report. Laryngoscope. 1992; 102:928–933.
Google Scholar | Crossref | Medline2. Bakshi, SS, Bhattacharjee, S. Juvenile nasopharyngeal angiofibroma. J Pediatr Hematol Oncol. 2016; 38(6):491–492.
Google Scholar | Crossref | Medline3. López F, Suárez V, Costales M, Suárez C, Llorente JL. Treatment of juvenile angiofibromas: 18-year experience of a single tertiary centre in Spain. Rhinology. 2012; 50:95–103.
Google Scholar | Crossref | Medline4. Sun, XC, Wang, DH, Yu, HP, et al. Analysis of risk factors associated with recurrence of nasopharyngeal angiofibroma. J Otolaryngol Head Neck Surg. 2010; 39:56–61.
Google Scholar | Medline5. Huang, Y, Liu, Z, Wang, J, et al. Surgical management of juvenile nasopharyngeal angiofibroma: analysis of 162 cases from 1995 to 2012. Laryngoscope. 2014; 124(8):1942–1946.
Google Scholar | Crossref | Medline6. Song, X, Wang, D, Sun, X, et al. Cumulative sum analysis of the learning curve for endoscopic resection of juvenile nasopharyngeal angiofibroma. Surg Endosc. 2018; 32(7):3181–3191.
Google Scholar | Crossref | Medline7. Wang, JJ, Sun, XC, Hu, L, et al. Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance. Head Neck. 2013; 35(12):1719–1725.
Google Scholar | Crossref | Medline8. Liu, Z, Wang, J, Wang, H, et al. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis. Acta Otolaryngol. 2015; 135(1):51–57.
Google Scholar | Crossref | Medline9. Wu J, Liu T, Rios Z, Mei Q, Lin X, Cao S. Heat shock proteins and cancer. Trends Pharmacol Sci. 2017; 38(3):226–256.
Google Scholar | Crossref | Medline10. Whitesell, L, Lindquist, SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer. 2005; 5(10):761–772.
Google Scholar | Crossref | Medline11. Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT. Angiofibroma: changes in staging and treatment. Arch Otolaryngol Head Neck Surg. 1996; 122(2):122–129.
Google Scholar | Crossref | Medline12. van Diest, PJ, van Dam, P, Henzen-Logmans, SC, et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European organization for research and treatment of cancer-gynaecological cancer cooperative group. J Clin Pathol. 1997; 50(10):801–804.
Google Scholar | Crossref | Medline13. Sun, X, Guo, L, Wang, J, et al. Prognostic value of matrix metalloproteinase 9 expression in patients with juvenile nasopharyngeal angiofibroma: tissue microarray analysis. Int J Pediatr Otorhinolaryngol. 2014; 78(8):1232–1238.
Google Scholar | Crossref | Medline14. Song, X, Yang, C, Zhang, H, et al. Hypoxia-Inducible factor-1alpha (HIF-1alpha) expression on endothelial cells in juvenile nasopharyngeal angiofibroma: a review of 70 cases and tissue microarray analysis. Ann Otol Rhinol Laryngol. 2018; 127(6):357–366.
Google Scholar | SAGE Journals15. Condelli, V, Crispo, F, Pietrafesa, M, et al. HSP90 molecular chaperones, metabolic rewiring, and epigenetics: impact on tumor progression and perspective for anticancer therapy. Cells. 2019; 8(6):532.
Google Scholar | Crossref16. Wei, W, Liu, M, Ning, S, et al. Diagnostic value of plasma HSP90alpha levels for detection of hepatocellular carcinoma. BMC Cancer. 2020; 20(1):6.
Google Scholar | Crossref | Medline17. Sanchez, ER. Chaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperones. Biochim Biophys Acta. 2012; 1823(3):722–729.
Google Scholar | Crossref | Medline18. Smith DF, Whitesell L, Nair SC, Chen S, Prapapanich V, Rimerman RA. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol. 1995; 15(12):6804–6812.
Google Scholar | Crossref | Medline19. Zeisberg, EM, Tarnavski, O, Zeisberg, M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007; 13(8):952–961.
Google Scholar | Crossref | Medline20. Potenta, S, Zeisberg, E, Kalluri, R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer. 2008; 99(9):1375–1379.
Google Scholar | Crossref | Medline